Marshall Wace North America L.P. - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$139,000
+631.6%
26,252
+1283.9%
0.00%
Q1 2020$19,0001,8970.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 1,717,589$3,006,0001.17%
SV Health Investors, LLC 311,490$545,0000.66%
Bain Capital Life Sciences Investors, LLC 3,019,540$5,284,0000.51%
AIGH Capital Management LLC 997,719$1,746,0000.43%
Ikarian Capital, LLC 1,372,022$2,402,0000.32%
New Leaf Venture Partners, L.L.C. 335,000$586,0000.29%
Worth Venture Partners, LLC 250,144$438,0000.20%
Sio Capital Management, LLC 276,909$485,0000.16%
BVF INC/IL 847,879$1,484,0000.06%
Orbimed Advisors 1,373,849$2,404,0000.04%
View complete list of X4 PHARMACEUTICALS INC shareholders